Florida Citrus Mutual Inc., FDA has issued a proposed rule ( 90 FR 37817) which would change the standard of identity for pasteurized orange juice in 21 CFR 146.140 by lowering the required minimum ...

On June 30, 2025, FDA’s Human Foods Program published its proposed 2025 guidance agenda, including the Agency’s priority ...

The Food and Drug Administration is launching a new program to ramp up the United States’ domestic pharmaceutical supply chain, the agency announced Thursday. The program, called FDA ...

Teva (TEVA) stock in focus as the FDA expands label for its migraine therapy Ajovy for children and adolescents aged 6–17 years. Read more here.

Zoetis, Inc. ZTS delivered second-quarter 2025 adjusted earnings (excluding one-time items) of $1.76 per share, which ...

The FDA is requiring opioid pain medication manufacturers to update safety labeling with a stronger emphasis on risks from ...

The Food and Drug Administration July 31 announced that it is requiring safety label changes to all opioid pain medications ...

The U.S. Food and Drug Administration plans to require new labels on all opioid pain medications that emphasizes long-term ...

The U.S. Food and Drug Administration is taking significant steps in the ongoing fight against the Opioid Crisis.

By Niveditha Ravishankar, R&D Manager, McCain Foods Key takeaways: Regulatory and consumer pressure are rising: U.S.

Numerous recalls have been initiated in 2025 due to the potential for damaged products, foodborne illness, contamination and ...

Apellis Pharma (APLS) stock in focus as the FDA expands the label for its injectable therapy Empaveli to treat rare kidney ...